Chordia Therapeutics,Inc Logo

Chordia Therapeutics,Inc

Clinical-stage biotech developing novel cancer therapies targeting RNA deregulation.

190A | T

Overview

Corporate Details

ISIN(s):
JP3283730004
LEI:
Country:
Japan
Address:
藤沢市村岡東2−26−1

Description

Chordia Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the research and development of novel cancer therapies. The company focuses on discovering and developing first-in-class, small-molecule drugs that target RNA deregulation, a key driver in various cancers. Its mission is to create life-changing treatments for patients by advancing a pipeline of innovative drug candidates from preclinical research through clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 05:00
確認書
Japanese 8.1 KB
2025-11-21 05:00
有価証券報告書-第8期(2024/09/01-2025/08/31)
Japanese 2.6 MB
2025-09-05 08:30
有価証券届出書(参照方式)
Japanese 534.8 KB
2025-05-16 02:45
臨時報告書
Japanese 20.2 KB
2025-04-11 04:50
半期報告書-第8期(2024/09/01-2025/08/31)
Japanese 144.4 KB
2025-04-11 04:50
確認書
Japanese 8.1 KB
2024-12-17 07:30
訂正確認書
Japanese 8.7 KB
2024-11-29 07:37
臨時報告書
Japanese 23.1 KB
2024-11-29 07:36
確認書
Japanese 8.1 KB
2024-11-29 07:35
内部統制報告書-第7期(2023/09/01-2024/08/31)
Japanese 21.2 KB
2024-11-29 07:34
有価証券報告書-第7期(2023/09/01-2024/08/31)
Japanese 2.8 MB
2024-07-16 06:55
四半期報告書-第7期第3四半期(2024/03/01-2024/05/31)
Japanese 123.4 KB
2024-07-16 06:55
確認書
Japanese 8.0 KB
2024-06-06 08:00
訂正有価証券届出書(新規公開時)
Japanese 2.9 MB
2024-05-29 04:00
訂正有価証券届出書(新規公開時)
Japanese 2.9 MB

Automate Your Workflow. Get a real-time feed of all Chordia Therapeutics,Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chordia Therapeutics,Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chordia Therapeutics,Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.